Botswana
Research assessment: Unrated · Confidence C · Southern Africa
Held after secondary AI review; no published rating
Secondary AI review
Retain provisional3/C but hold live headline grey. Verified local provisional amounts justify D4=2; current audited insurer and legal-scope/currency gaps prevent Ready publication.
Official NBFIRA report and local Bona Life2024 report freshly read. BPOMAS audited medical-aid evidence retained in review files as adjacent scope; not counted as a licensed insurer audit. No market or subsidiary extrapolation.
Dimensions
| Dimension | Score | Evidence assessment |
|---|---|---|
| D1 | 4 | Supervisor expressly states an in-force IFRS17 obligation from January 2023 for all insurance companies. Standalone legal incorporation text and full equivalence/carve-out check are not complete, so 5 is not claimed. |
| D2 | 4 | Broad life, general and reinsurance reporting perimeter is explicit. Medical-aid schemes operate separately under exemption letters; their fiscal-year transition and full population are not collapsed into licensed insurers. |
| D3 | 5 | Requirement effective January 2023; multiple annual periods have ended by cutoff and local 2024 IFRS17 reporting is observed. This is timing/maturity inference, not proof that every company completed each cycle; no blanket extension was identified in the checked sources. |
| D4 | 2 | Fresh Bona Life local IFRS17 published-basis amounts and statutory-actuary summary support incomplete implementation evidence under D4=2. The reviewer blind null is revised because rubric2 expressly allows incomplete/provisional evidence; no licensed-insurer audit is inferred. BIHL2025 remained inaccessible and BPOMAS medical-aid audit is adjacent scope only. |
| D5 | 3 | Supervisor distinguishes IFRS17 and IFRS4 populations in operational industry data and monitors transition. No current complete-market reconciliation or enforcement outcomes were verified. |
Remaining evidence gaps and limits
- Fresh audited local operating-insurer IFRS17 policy, amounts and opinion remain unverified.
- BIHL2025 primary URL inaccessible on18October2026; historical claim retained but not counted.
- Current2026 scope/exclusions and blanket-relief search are incomplete; latest supervisor financial data checked concerns2023.
- Representative non-life/reinsurance audited sample is missing.
Sources
- Non-Bank Financial Institutions Regulatory Authority Botswana: Annual Report2024. PDF pp.22,36,40–41; printed pp.11,25,29–30; financial-industry section and footnote to market aggregates. Official non-binding; tier A2. Published date not established; accessed 2026-10-13; rechecked 2026-10-18. Insurance statistics include IFRS17 reporting entities only; other entities omitted during transition. Medical aids mostly IFRS4. Restated2022 IFRS17 comparisons used. Official supervisory reporting observation Secondary verification: 2026-10-18. Original source access date retained. Official statement of requirement, not the standalone legal endorsement instrument; financial evidence relates to December 2023, not a current complete-market census.
- Botswana Insurance Holdings Limited: Consolidated and Separate Financial Statements2025. Printed p12 audit KAM; pp5-6 regulatory vs published basis; note14 p95; note4 p25. Entity filing; tier A3. Published 2026-05-22; accessed 2026-10-13; rechecked 2026-10-18. Auditor KAM explicitly describes Group IFRS17 contract measurement and2024 comparatives. Regulatory valuation adds solvency margins absent from IFRS17. BURS approval for IFRS17 tax received Nov2025. Audited consolidated group; parent separate accounts are non-insurer | 18 October 2026 fresh recheck failed. Prior content metadata is retained historically but excluded from the current decisive evidence basis. No inference that the historical claim is false. Secondary verification: 2026-10-18. Original source access date retained.
- Bona Life: Annual Report 2023/2024. PDF pp.11,13–14; financial highlights and statutory actuary summary. Entity filing; tier A3. Published date not established; accessed 2026-10-18. Local life insurer presents IFRS17 published-basis amounts and a statutory-actuary summary for year ended 31 March 2024. Independent audit opinion is not present in the 19-page document reviewed. This is incomplete audit proof, not proof that no audit exists. Supports D4=2 only; no current market-coverage claim.
Current evidence claims
- CLM-BWA-2026-C001 (D5): NBFIRA publishes IFRS17-based insurance sector analysis but identifies incomplete coverage during transition.
- CLM-BWA-2026-C002 (D4): BIHL2025 audited Group applies IFRS17 to insurance contracts; audited insurance balances and2024 comparatives disclosed.
- CLM-BWA-2026-C003 (D5): BIHL describes separate regulatory solvency valuation and published IFRS17 valuation.
- CLM-BWA-2026-R001 (D1): NBFIRA states all insurance companies are required to comply with IFRS17 for annual periods beginning on or after1January2023.
- CLM-BWA-2026-R002 (D2): NBFIRA2024 report selectedIFRS17lifeinsurers represented77%GWP/81%assets, generalinsurers63%GWP/58%assets; allreinsurers submittedIFRS17results.
- CLM-BWA-2026-S2001 (D4): Bona Life presents local IFRS17 published-basis 2024 amounts with a statutory-actuary summary; independent audit proof is incomplete in the reviewed report.
Later research follow-up
25 October 2026 research update. This follow-up does not change the published assessment or its evidence cutoff.